Terapevticheskii arkhivTerapevticheskii arkhivТерапевтический архив0040-36602309-5342LLC Obyedinennaya Redaktsiya30219Editorial articleПередовая статьяResearch ArticleFatal complications of long-term immunosuppressive therapy in a renal transplant recipientФатальные осложнения длительной иммуносупрессивной терапии у реципиента почечного трансплантатаRekhtinaI GРехтинаИ ГBiriukovaL SБирюковаЛ СГУ Гематологический научный центр РАМН, Москва15072008807VOL 80, NO7 ()ТОМ 80, №7 (2008)626409042020Copyright ©; 2008, Consilium MedicumCopyright ©; 2008, ООО "Консилиум Медикум"2008Consilium MedicumООО "Консилиум Медикум"https://creativecommons.org/licenses/by-nc-sa/4.0https://ter-arkhiv.ru/0040-3660/article/view/30219transplantation of the kidneyimmunosuppressiontherapymultiple myelomamonoclonal secretioтрансплантация почкииммуносупрессиятерапиямножественная миеломамоноклональная секреци[Касиске Б. Л. Поздний посттрансплантационный период и его осложнения. В кн.: Данович Г. М. (ред.) Руководство по трансплантации почки. Тверь: Триада; 2004. 214-254.][Akioka К., Okamoto М., Nakamura К. et al. Hypertrophic cardiomyopathy in a renal trasplant recipient: a case report. Transplant. Proc. 2003; 35: 269-270.][Chang R. K., McDiarmid S. V., Alejos J. С. et al. Echocardiography findings of hypertrophic cardiomyopathy in children after orthotopic liver transplantation. Pediatr. Transplant. 2001; 5 (3): 187-191.][Jarzembowski Т. M., John E., Panaro F. et al. Reversal of tacrolimus-related hypertrophic obstructive cardiomyopathy 5 years after kidney transplant in 6-year-old recipient. Pediatr. Transplant. 2005; 9 (1): 117-121.][Caillard S., Agodoa L. Y., Bohen E. M., Abbott К. C. Myeloma, Hodgkin disease, and lymphoid leukemia after renal transplantation: characteristics, risk factors and prognos. Transplantation 2006; 81: 888-895.][Passweg J., Thiel G., Bock H. A. Monoclonal gammopathy after intense induction immunosuppression in renal transplant patients. Nephrol. Dial. Transplant. 1996; 11(12): 2461-2465.][Chakalarovski C., Lang P., Buisson C. et al. Monoclonal immunoglobulins in patients with renal transplants: characterization, evolution and risk factors. Transplant. Int. 1992; 5: 23-25.][Sun X., Peterson L. G., Gong Y. et al. Post-transplant plasma cell myeloma and polymorphic lymphoproliferative disorder with monoclonal serum protein occurring in solid organ transplant recipients. Mod. Pathol. 2004; 17 (4): 389-394.][Ancin I., Sarra J., Peris J. et al. Demonstration of Epstein-Barr virus in a case of multiple myeloma after renal transplantation. Haematologica 2000; 85 (7): 773-774.][Nalesnik M. A. Clinicopathologic characteristics of posttransplant lymphoproliferative disorders. Recent Results Cancer Res. 2002; 159: 9-18.][Cacciola E., Giustolisi R., Guglielo P., Cacciola E. Multiple myeloma and renal transplant. Haematologica 1994; 79: 73-75.][Gupta A., Shenton В., Gok M. et al. Plasma cell myeloma variant of post-transplant lymphoproliferative disorder in a solid organ transplant recipient: a case report. Nephrol. Dial. Transplant. 2004; 19 (12): 3186-3189.][Rees L., Thomas A., Amlot P. L. Disappearance of an Epstein-Barr vims-positive post-transplant plasmacytoma with reduction of immunosupression. Lancet 1998; 352: 789.][Berthelemy C., Mourad G., Bataille R. et al. Occurrence of multiple myeloma 5 years after renal transplantation. Presse Med. 1988; 17: 1706.]